naphthalimides has been researched along with Pancreatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; Ge, H; Li, H; Liu, J; Peng, X; Shao, K; Xian, L; Xiao, G; Xu, F; Xu, N | 1 |
| Alfahad, M; Curtis, A; Hoskins, C; Jones, S; Kong Thoo Lin, P; Malekigorji, M | 1 |
| Cheng, WP; Cordeiro-da-Silva, A; Hoskins, C; Kong Thoo Lin, P; Lima, SC; Lombardo, D; Loureirio, I; Mas, E; Ouaissi, A; Ouaissi, M | 1 |
| Abbruzzese, JL; Ajani, JA; Bradof, JE; Daugherty, K; Levin, B; Linke, K; Pazdur, R; Winn, R | 1 |
1 trial(s) available for naphthalimides and Pancreatic Neoplasms
| Article | Year |
|---|---|
Phase II study of amonafide in advanced pancreatic adenocarcinoma.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates; Pancreatic Neoplasms | 1991 |
3 other study(ies) available for naphthalimides and Pancreatic Neoplasms
| Article | Year |
|---|---|
MicroRNA Detection with Turnover Amplification via Hybridization-Mediated Staudinger Reduction for Pancreatic Cancer Diagnosis.
Topics: Animals; Biosensing Techniques; Cells, Cultured; Fluorescent Dyes; Humans; Mice; MicroRNAs; Molecular Structure; Naphthalimides; NIH 3T3 Cells; Nucleic Acid Hybridization; Optical Imaging; Oxidation-Reduction; Pancreatic Neoplasms | 2019 |
Thermally triggered theranostics for pancreatic cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Liberation; Female; Gold; Hot Temperature; Humans; Metal Nanoparticles; Mice, Nude; Naphthalimides; Pancreatic Neoplasms; Theranostic Nanomedicine | 2017 |
In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; In Vitro Techniques; Inhibitory Concentration 50; Mice; Nanotechnology; Naphthalimides; Pancreatic Neoplasms; Polymers; Xenograft Model Antitumor Assays | 2010 |